Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Klerfalk Pharma AB

Closing information (x1000 DKK)

Closing information 2023/12 2022/12 2021/12
Turnover 718 More Arrow 761 More Arrow 1,192
Financial expenses 1,994 Less Arrow 359 More Arrow 2,258
Earnings before taxes 115 Less Arrow -229 More Arrow 4,947
EBITDA 50 More Arrow 115 More Arrow 441
Total assets 7,863 Less Arrow 7,776 More Arrow 8,803
Current assets 446 More Arrow 812 More Arrow 1,227
Current liabilities 247 More Arrow 313 More Arrow 406
Equity capital 7,542 Less Arrow 7,380 More Arrow 8,317
- share capital 34 Less Arrow 33 More Arrow 36
Employees (average) 1 Equal arrow 1 Equal arrow 1

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 95.9% Less Arrow 94.9% Less Arrow 94.5%
Turnover per employee 718 More Arrow 761 More Arrow 1,192
Profit as a percentage of turnover 16.0% Less Arrow -30.1% More Arrow 415.0%
Return on assets (ROA) 26.8% Less Arrow 1.7% More Arrow 81.8%
Current ratio 180.6% More Arrow 259.4% More Arrow 302.2%
Return on equity (ROE) 1.5% Less Arrow -3.1% More Arrow 59.5%
Change turnover -47 Less Arrow -334 More Arrow 380
Change turnover % -6% Less Arrow -31% More Arrow 47%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.